{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T15:38:26Z","timestamp":1770824306657,"version":"3.50.1"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>General surgery for patients with lymphangioleiomyomatosis (LAM) is infrequent, however, general surgeons also occasionally experience it. Only a few reports have described the specific perioperative management appropriate for patients with LAM. Hence, in this case series, we aimed to investigate the surgical outcomes of LAM patients and their characteristics.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Medical records of 4482 patients who underwent thoracic surgery between 2009 and 2017 at our institution were assessed. Twelve patients were diagnosed with LAM. Details of the postoperative courses and surgical outcomes of LAM patients were retrospectively examined.<\/jats:p>\n                <jats:p>All LAM patients were female (age 41.3\u2009\u00b1\u200910.6\u00a0years). Surgeries were performed for patients undergoing biopsy (<jats:italic>n<\/jats:italic>\u2009=\u20094) and those with pneumothorax (<jats:italic>n<\/jats:italic>\u2009=\u20093), lung cancer (<jats:italic>n<\/jats:italic>\u2009=\u20092), and other conditions (<jats:italic>n<\/jats:italic>\u2009=\u20093). The mortality rate was 0% and the length of hospital stay was 27.4\u2009\u00b1\u20098.9\u00a0days. Ten postoperative complications occurred in six patients (50%): hypoxemia (<jats:italic>n<\/jats:italic>\u2009=\u20095), chylothorax (<jats:italic>n<\/jats:italic>\u2009=\u20092), and prolonged air leakage (<jats:italic>n<\/jats:italic>\u2009=\u20093).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Thoracic surgery may pose a risk of postoperative complications and long hospitalization for patients with LAM, although it lowers the risk of fatality. Management of perioperative air and chyle leakages and lymphatic stasis in the lungs is important for preventing morbidities.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40792-022-01507-5","type":"journal-article","created":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T03:24:47Z","timestamp":1659324287000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Perioperative management of thoracic surgery in patients with lymphangioleiomyomatosis"],"prefix":"10.1186","volume":"8","author":[{"given":"Mariko","family":"Fukui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuniaki","family":"Seyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aritoshi","family":"Hattori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuya","family":"Takamochi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiaki","family":"Oh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Izumi","family":"Kawagoe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,8,1]]},"reference":[{"key":"1507_CR1","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1164\/rccm.201709-1965ST","volume":"196","author":"N Gupta","year":"2017","unstructured":"Gupta N, Finlay GA, Kotloff RM, Strange C, Wilson KC, Young LR, et al. Lymphangioleiomyomatosis diagnosis and management: high-resolution chest computed tomography, transbronchial lung biopsy, and pleural disease management. An Official American Thoracic Society\/Japanese Respiratory Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2017;196:1337\u201348.","journal-title":"Am J Respir Crit Care Med"},{"key":"1507_CR2","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1111\/j.1440-1843.2007.01101.x","volume":"12","author":"M Hayashida","year":"2007","unstructured":"Hayashida M, Seyama K, Inoue Y, Fujimoto K, Kubo K, Respiratory Failure Research Group of the Japanese Ministry of Health L, et al. The epidemiology of lymphangioleiomyomatosis in Japan: a nationwide cross-sectional study of presenting features and prognostic factors. Respirology. 2007;12:523\u201330.","journal-title":"Respirology"},{"key":"1507_CR3","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1093\/qjmed\/hcr116","volume":"104","author":"EC Harknett","year":"2011","unstructured":"Harknett EC, Chang WY, Byrnes S, Johnson J, Lazor R, Cohen MM, et al. Use of variability in national and regional data to estimate the prevalence of lymphangioleiomyomatosis. QJM. 2011;104:971\u20139.","journal-title":"QJM"},{"key":"1507_CR4","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1378\/chest.07-0898","volume":"133","author":"FX McCormack","year":"2008","unstructured":"McCormack FX. Lymphangioleiomyomatosis: a clinical update. Chest. 2008;133:507\u201316.","journal-title":"Chest"},{"key":"1507_CR5","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.chest.2018.06.016","volume":"155","author":"N Gupta","year":"2019","unstructured":"Gupta N, Lee HS, Ryu JH, Taveira-DaSilva AM, Beck GJ, Lee JC, et al. The NHLBI LAM registry: prognostic physiologic and radiologic biomarkers emerge from a 15-year prospective longitudinal analysis. Chest. 2019;155:288\u201396.","journal-title":"Chest"},{"key":"1507_CR6","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1183\/09031936.00076209","volume":"35","author":"SR Johnson","year":"2010","unstructured":"Johnson SR, Cordier JF, Lazor R, Cottin V, Costabel U, Harari S, et al. European Respiratory Society guidelines for the diagnosis and management of lymphangioleiomyomatosis. Eur Respir J. 2010;35:14\u201326.","journal-title":"Eur Respir J"},{"key":"1507_CR7","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1378\/chest.129.5.1274","volume":"129","author":"KF Almoosa","year":"2006","unstructured":"Almoosa KF, Ryu JH, Mendez J, Huggins JT, Young LR, Sullivan EJ, et al. Management of pneumothorax in lymphangioleiomyomatosis: effects on recurrence and lung transplantation complications. Chest. 2006;129:1274\u201381.","journal-title":"Chest"},{"key":"1507_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0163637","volume":"11","author":"M Kurihara","year":"2016","unstructured":"Kurihara M, Mizobuchi T, Kataoka H, Sato T, Kumasaka T, Ebana H, et al. A total pleural covering for lymphangioleiomyomatosis prevents pneumothorax recurrence. PLoS ONE. 2016;11: e0163637.","journal-title":"PLoS ONE"},{"key":"1507_CR9","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1056\/NEJMoa1100391","volume":"364","author":"FX McCormack","year":"2011","unstructured":"McCormack FX, Inoue Y, Moss J, Singer LG, Strange C, Nakata K, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364:1595\u2013606.","journal-title":"N Engl J Med"},{"key":"1507_CR10","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.resinv.2013.03.002","volume":"51","author":"K Ando","year":"2013","unstructured":"Ando K, Kurihara M, Kataoka H, Ueyama M, Togo S, Sato T, et al. Efficacy and safety of low-dose sirolimus for treatment of lymphangioleiomyomatosis. Respir Investig. 2013;51:175\u201383.","journal-title":"Respir Investig"},{"issue":"4","key":"1507_CR11","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.resinv.2014.02.004","volume":"52","author":"K Suina","year":"2014","unstructured":"Suina K, Hayashi T, Mitani K, Suzuki K, Takahashi K, Seyama K. What\u05f3s the role of sirolimus on the treatment of lymphangioleiomyomatosis (LAM)?: Merely tuning up of LAM-associated dysfunctional lymphatic vessels rather than cytoreduction? Respir Investig. 2014;52(4):274\u20136.","journal-title":"Respir Investig"},{"key":"1507_CR12","doi-asserted-by":"publisher","first-page":"944","DOI":"10.1007\/s00595-018-1678-z","volume":"48","author":"H Oishi","year":"2018","unstructured":"Oishi H, Watanabe T, Matsuda Y, Noda M, Ejima Y, Saiki Y, et al. Single lung transplantation for lymphangioleiomyomatosis: a single-center experience in Japan. Surg Today. 2018;48:944\u201350.","journal-title":"Surg Today"},{"key":"1507_CR13","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.transproceed.2015.04.103","volume":"47","author":"T Nakagiri","year":"2015","unstructured":"Nakagiri T, Shintani Y, Minami M, Inoue M, Funaki S, Kawamura T, et al. Lung transplantation for lymphangioleiomyomatosis in a single japanese institute, with a focus on late-onset complications. Transplant Proc. 2015;47:1977\u201382.","journal-title":"Transplant Proc"},{"key":"1507_CR14","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.jtcvs.2019.03.090","volume":"158","author":"K Suzuki","year":"2019","unstructured":"Suzuki K, Saji H, Aokage K, Watanabe SI, Okada M, Mizusawa J, et al. Comparison of pulmonary segmentectomy and lobectomy: safety results of a randomized trial. J Thorac Cardiovasc Surg. 2019;158:895\u2013907.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"1507_CR15","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1097\/TP.0b013e31817c15df","volume":"86","author":"M Reynaud-Gaubert","year":"2008","unstructured":"Reynaud-Gaubert M, Mornex JF, Mal H, Treilhaud M, Dromer C, Qu\u00e9tant S, et al. Lung transplantation for lymphangioleiomyomatosis: the French experience. Transplantation. 2008;86:515\u201320.","journal-title":"Transplantation"},{"key":"1507_CR16","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.transproceed.2010.12.051","volume":"43","author":"TN Machuca","year":"2011","unstructured":"Machuca TN, Losso MJ, Camargo SM, Schio SM, Melo IA, Hochhegger B, et al. Lung transplantation for lymphangioleiomyomatosis: single-center Brazilian experience with no chylothorax. Transplant Proc. 2011;43:236\u20138.","journal-title":"Transplant Proc"},{"key":"1507_CR17","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1183\/09031936.06.00113303","volume":"27","author":"SR Johnson","year":"2006","unstructured":"Johnson SR. Lymphangioleiomyomatosis. Eur Respir J. 2006;27:1056\u201365.","journal-title":"Eur Respir J"},{"key":"1507_CR18","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1164\/rccm.200409-1298OC","volume":"173","author":"JH Ryu","year":"2006","unstructured":"Ryu JH, Moss J, Beck GJ, Lee JC, Brown KK, Chapman JT, et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med. 2006;173:105\u201311.","journal-title":"Am J Respir Crit Care Med"},{"key":"1507_CR19","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000444264","volume":"91","author":"A Lama","year":"2016","unstructured":"Lama A, Ferreiro L, Golpe A, Gude F, \u00c1lvarez-Doba\u00f1o JM, Gonz\u00e1lez-Barcala FJ, et al. Characteristics of patients with lymphangioleiomyomatosis and pleural effusion: a systematic review. Respiration. 2016;91:256\u201364.","journal-title":"Respiration"},{"key":"1507_CR20","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1378\/chest.123.2.623","volume":"123","author":"JH Ryu","year":"2003","unstructured":"Ryu JH, Doerr CH, Fisher SD, Olson EJ, Sahn SA. Chylothorax in lymphangioleiomyomatosis. Chest. 2003;123:623\u20137.","journal-title":"Chest"},{"key":"1507_CR21","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/BF02282346","volume":"41","author":"E Calvo","year":"1996","unstructured":"Calvo E, Amarillas L, Mateos MA, Orradre JL, Gilsanz G, Alvarez-Sala JL, et al. Lymphangioleiomyomatosis, chylous ascites, and diet. Dig Dis Sci. 1996;41:591\u20133.","journal-title":"Dig Dis Sci"},{"key":"1507_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03345","volume":"6","author":"Y Ko","year":"2020","unstructured":"Ko Y, Asakawa K, Tobino K, Oguma T, Hirai T, Takada T, et al. Quantitative analysis of computed tomography of the lungs in patients with lymphangioleiomyomatosis treated with sirolimus. Heliyon. 2020;6: e03345.","journal-title":"Heliyon"},{"key":"1507_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0146749","volume":"11","author":"K Ando","year":"2016","unstructured":"Ando K, Okada Y, Akiba M, Kondo T, Kawamura T, Okumura M, et al. Lung transplantation for lymphangioleiomyomatosis in Japan. PLoS ONE. 2016;11: e0146749.","journal-title":"PLoS ONE"},{"key":"1507_CR24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S1053-2498(03)00309-7","volume":"23","author":"J Groetzner","year":"2004","unstructured":"Groetzner J, Kur F, Spelsberg F, Behr J, Frey L, Bittmann I, et al. Airway anastomosis complications in de novo lung transplantation with sirolimus-based immunosuppression. J Heart Lung Transplant. 2004;23:632\u20138.","journal-title":"J Heart Lung Transplant"},{"key":"1507_CR25","doi-asserted-by":"publisher","first-page":"1437","DOI":"10.1097\/01.TP.0000064083.02120.2C","volume":"75","author":"MB King-Biggs","year":"2003","unstructured":"King-Biggs MB, Dunitz JM, Park SJ, Kay Savik S, Hertz MI. Airway anastomotic dehiscence associated with use of sirolimus immediately after lung transplantation. Transplantation. 2003;75:1437\u201343.","journal-title":"Transplantation"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40792-022-01507-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-022-01507-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T03:25:37Z","timestamp":1659324337000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-022-01507-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1507"],"URL":"https:\/\/doi.org\/10.1186\/s40792-022-01507-5","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,1]]},"assertion":[{"value":"16 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the ethics committee of the Juntendo University School of Medicine (No. 21-085) and performed in accordance with the guidelines of the Declaration of Helsinki and its subsequent amendments. Informed consent was obtained using the opt-out on the website method.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"145"}}